ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Ensysce Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.50−0.02 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $6.56M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 10, 2025(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Dec 6, 2024 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 31, 2023 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Oct 28, 2022 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Aug 16, 2021(first seen in filings) | 9-for-4 | Earlier per-share figures divided by 2.25 |